GB2321190B - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number: GB2321190B
Authority: GB; United Kingdom
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 1997-01-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

GB9700855A

Other versions

GB9700855D0 (en

GB2321190A (en

Inventor

Derek Alan Woodcock

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Britannia Pharmaceuticals Ltd

Original Assignee

Britannia Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-16

Filing date

1997-01-16

Publication date

2000-09-20

1997-01-16 Application filed by Britannia Pharmaceuticals Ltd filed Critical Britannia Pharmaceuticals Ltd

1997-01-16 Priority to GB9700855A priority Critical patent/GB2321190B/en

1997-03-05 Publication of GB9700855D0 publication Critical patent/GB9700855D0/en

1998-01-14 Priority to PCT/GB1998/000105 priority patent/WO1998031355A2/en

1998-07-22 Publication of GB2321190A publication Critical patent/GB2321190A/en

2000-09-20 Application granted granted Critical

2000-09-20 Publication of GB2321190B publication Critical patent/GB2321190B/en

2017-01-16 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GB9700855A 1997-01-16 1997-01-16 Pharmaceutical composition Expired - Fee Related GB2321190B (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GB9700855A GB2321190B (en)	1997-01-16	1997-01-16	Pharmaceutical composition
PCT/GB1998/000105 WO1998031355A2 (en)	1997-01-16	1998-01-14	Pharmaceutical composition comprising n-propylnorapomorphine and cathecol-o-methyl-transferase inhibitor for treating parkinson's disease

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9700855A GB2321190B (en)	1997-01-16	1997-01-16	Pharmaceutical composition

Publications (3)

Publication Number	Publication Date
GB9700855D0 GB9700855D0 (en)	1997-03-05
GB2321190A GB2321190A (en)	1998-07-22
GB2321190B true GB2321190B (en)	2000-09-20

Family

ID=10806094

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB9700855A Expired - Fee Related GB2321190B (en)	1997-01-16	1997-01-16	Pharmaceutical composition

Country Status (2)

Country	Link
GB (1)	GB2321190B (en)
WO (1)	WO1998031355A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI109453B (en) *	1999-06-30	2002-08-15	Orion Yhtymae Oyj	Pharmaceutical composition
EP1325152A2 (en) *	2000-07-14	2003-07-09	F. Hoffmann-La Roche Ag	Method for detecting pre-disposition to hepatotoxicity
FI20012242A0 (en) *	2001-11-19	2001-11-19	Orion Corp	New pharmaceutical compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3717643A (en) *	1967-05-04	1973-02-20	Sterling Drug Inc	N-substituted-norapomorphines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU3140577A (en) *	1976-12-13	1979-06-14	Sterling Drug Inc	N-propylnorapormorphine diesters
US4469695A (en) *	1980-02-25	1984-09-04	Ayerst, Mckenna & Harrison, Inc.	2-(4-Hydroxyalkyl-1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives
US5496836A (en) *	1994-05-05	1996-03-05	Mount Sinai School Of Medicine Of The City University Of New York	Use of famotidine and related compounds in the treatment of movement disorders
JPH11505828A (en) *	1995-05-26	1999-05-25	ファイザー・インコーポレーテッド	Selective NMDA antagonist containing combinations for the treatment of Parkinson's syndrome

1997
- 1997-01-16 GB GB9700855A patent/GB2321190B/en not_active Expired - Fee Related
1998
- 1998-01-14 WO PCT/GB1998/000105 patent/WO1998031355A2/en not_active Ceased

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3717643A (en) *	1967-05-04	1973-02-20	Sterling Drug Inc	N-substituted-norapomorphines

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Biosis No: 67062980 & Archives of Neurology 35(12), 1978, pages 787 - 791. *
Chemical Abstract No: 125:48284 & Eur. J. Clin. Pharmacology50(1/2), 1996, pages 47 - 55. *
Chemical Abstract No: 125:49128 & Clin. Neuropharmacology 19(3), 1996, pages 222 - 223. *

Also Published As

Publication number	Publication date
WO1998031355A2 (en)	1998-07-23
WO1998031355A3 (en)	1998-09-11
GB9700855D0 (en)	1997-03-05
GB2321190A (en)	1998-07-22

Publication	Publication Date	Title
GB9706089D0 (en)	1997-05-14	Pharmaceutical composition
GB9727053D0 (en)	1998-02-18	Pharmaceutical compositions
EP0978288A4 (en)	2006-07-12	Medicinal composition
IL133928A0 (en)	2001-04-30	Pharmaceutical composition containing peptichemio
GB9717444D0 (en)	1997-10-22	Pharmaceutical composition
HUP0002455A3 (en)	2001-01-29	Gastric-retained pharmaceutical composition
AP9901657A0 (en)	1999-09-30	Pharmaceutical compositions
GB9717428D0 (en)	1997-10-22	Pharmaceutical composition
GB9723985D0 (en)	1998-01-14	Pharmaceutical compositions
ZA9811532B (en)	1999-06-18	Pharmaceutical compositions
IL122920A (en)	2009-09-01	Castrointestinal drug composition
HU9700632D0 (en)	1997-05-28	Pharmaceutical compositions
GB9623962D0 (en)	1997-01-08	Pharmaceutical composition
GB9717770D0 (en)	1997-10-29	Pharmaceutical composition
GB2321190B (en)	2000-09-20	Pharmaceutical composition
GB9921495D0 (en)	1999-11-17	Pharmaceutical compositions
GB9726781D0 (en)	1998-02-18	Pharmaceutical composition
HU9800078D0 (en)	1998-04-28	Pharmaceutical composition
GB9718270D0 (en)	1997-11-05	Pharmaceutical compositions
GB9717575D0 (en)	1997-10-22	Pharmaceutical composition
GB9710525D0 (en)	1997-07-16	Pharmaceutical composition
GB9710632D0 (en)	1997-07-16	Pharmaceutical composition
GB9712097D0 (en)	1997-08-13	Pharmaceutical composition
HU9701598D0 (en)	1997-11-28	Pharmaceutical composition
GB9727238D0 (en)	1998-02-25	Pharmaceutical composition

Legal Events

Date	Code	Title	Description
2006-09-27	PCNP	Patent ceased through non-payment of renewal fee	Effective date: 20060116